WO2002015894A3 - Use of vitamin d derivatives as bone resorption inhibitors - Google Patents
Use of vitamin d derivatives as bone resorption inhibitors Download PDFInfo
- Publication number
- WO2002015894A3 WO2002015894A3 PCT/US2001/022614 US0122614W WO0215894A3 WO 2002015894 A3 WO2002015894 A3 WO 2002015894A3 US 0122614 W US0122614 W US 0122614W WO 0215894 A3 WO0215894 A3 WO 0215894A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vitamin
- bone resorption
- derivatives
- resorption inhibitors
- bone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU8465701A AU8465701A (en) | 2000-08-23 | 2001-08-22 | Use of vitamin d derivatives as bone resorption inhibitors |
EP01963731A EP1311253A2 (en) | 2000-08-23 | 2001-08-22 | Use of vitamin d derivatives as bone resorption inhibitors |
US10/362,565 US20040019024A1 (en) | 2000-08-23 | 2001-08-22 | Use of vitamin d derivatives as bone resorption inhibitors |
NZ524305A NZ524305A (en) | 2000-08-23 | 2001-08-22 | Use of vitamin D derivatives as bone resorption inhibitors |
CA002420274A CA2420274A1 (en) | 2000-08-23 | 2001-08-22 | Use of vitamin d derivatives as bone resorption inhibitors |
AU2001284657A AU2001284657B2 (en) | 2000-08-23 | 2001-08-22 | Use of vitamin d derivatives as bone resorption inhibitors |
JP2002520815A JP2004528269A (en) | 2001-08-22 | 2001-08-22 | Use of vitamin D derivatives as bone resorption inhibitors |
NO20030820A NO20030820L (en) | 2000-08-23 | 2003-02-21 | Use of vitamin D derivatives as bone resorption inhibitors |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-252177 | 2000-08-23 | ||
JP2000252177A JP2002069003A (en) | 2000-08-23 | 2000-08-23 | Deossification inhibitor containing vitamin d derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002015894A2 WO2002015894A2 (en) | 2002-02-28 |
WO2002015894A3 true WO2002015894A3 (en) | 2002-08-29 |
Family
ID=18741464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/022614 WO2002015894A2 (en) | 2000-08-23 | 2001-08-22 | Use of vitamin d derivatives as bone resorption inhibitors |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1311253A2 (en) |
JP (1) | JP2002069003A (en) |
AU (2) | AU8465701A (en) |
CA (1) | CA2420274A1 (en) |
NO (1) | NO20030820L (en) |
NZ (1) | NZ524305A (en) |
WO (1) | WO2002015894A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050101575A1 (en) * | 2002-02-20 | 2005-05-12 | Karuya Takenouchi | Vitamin d3 derivatives and remedies using the same |
EP1342796A3 (en) * | 2002-02-22 | 2004-01-02 | Teijin Limited | Compound for the treatment of paget's disease of bone |
US9073885B2 (en) | 2003-01-30 | 2015-07-07 | Teijin Pharma Limited | Vitamin D3 lactone derivatives |
US7524980B2 (en) | 2003-11-04 | 2009-04-28 | Teijin Pharma Limited | Vitamin D3 lactam derivative |
KR20060111549A (en) * | 2003-11-04 | 2006-10-27 | 데이진 화-마 가부시키가이샤 | Vitamin d3 lactam derivative |
JP2007070281A (en) * | 2005-09-06 | 2007-03-22 | Matsumoto Shika Univ | Remedy for osteoporosis produced by using retinoid x receptor-relating compound |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5093519A (en) * | 1988-05-04 | 1992-03-03 | Ire-Medgenix S.A. | Vitamin d derivatives: therapeutic applications and applications to assays of metabolities of vitamin d |
DE19744127A1 (en) * | 1997-10-01 | 1999-04-15 | Schering Ag | New vitamin D derivatives with cyclopropyl rings in the side chains, processes and intermediates for their manufacture and their use in the manufacture of pharmaceuticals |
WO2000024712A1 (en) * | 1998-10-23 | 2000-05-04 | Teijin Limited | Vitamin d3 derivatives and remedies for inflammatory respiratory diseases containing the same |
-
2000
- 2000-08-23 JP JP2000252177A patent/JP2002069003A/en not_active Withdrawn
-
2001
- 2001-08-22 WO PCT/US2001/022614 patent/WO2002015894A2/en active IP Right Grant
- 2001-08-22 AU AU8465701A patent/AU8465701A/en active Pending
- 2001-08-22 AU AU2001284657A patent/AU2001284657B2/en not_active Ceased
- 2001-08-22 EP EP01963731A patent/EP1311253A2/en not_active Withdrawn
- 2001-08-22 CA CA002420274A patent/CA2420274A1/en not_active Abandoned
- 2001-08-22 NZ NZ524305A patent/NZ524305A/en unknown
-
2003
- 2003-02-21 NO NO20030820A patent/NO20030820L/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5093519A (en) * | 1988-05-04 | 1992-03-03 | Ire-Medgenix S.A. | Vitamin d derivatives: therapeutic applications and applications to assays of metabolities of vitamin d |
DE19744127A1 (en) * | 1997-10-01 | 1999-04-15 | Schering Ag | New vitamin D derivatives with cyclopropyl rings in the side chains, processes and intermediates for their manufacture and their use in the manufacture of pharmaceuticals |
WO2000024712A1 (en) * | 1998-10-23 | 2000-05-04 | Teijin Limited | Vitamin d3 derivatives and remedies for inflammatory respiratory diseases containing the same |
Also Published As
Publication number | Publication date |
---|---|
WO2002015894A2 (en) | 2002-02-28 |
AU2001284657B2 (en) | 2006-01-19 |
NO20030820L (en) | 2003-04-22 |
EP1311253A2 (en) | 2003-05-21 |
AU8465701A (en) | 2002-03-04 |
NO20030820D0 (en) | 2003-02-21 |
NZ524305A (en) | 2004-08-27 |
CA2420274A1 (en) | 2002-02-28 |
JP2002069003A (en) | 2002-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003225617A1 (en) | Thiadiazolylpiperazine derivatives useful for treating or preventing pain | |
IL165264A (en) | Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases | |
GB0005251D0 (en) | Therapeutic compounds | |
BR0212042A (en) | Compound, pharmaceutical composition, method of treating or preventing disease, and use of a compound | |
GEP20053631B (en) | ) New Spirotricyclic Derivatives and Their Use as Phosphodiesterase-7 Inhibitors | |
WO2004029031A3 (en) | Therapeutic piperazine compounds | |
WO1999004772A3 (en) | Use of levobupivacaine | |
WO1999049854A3 (en) | Use of dexmedetomidine for icu sedation | |
WO2003002105A3 (en) | Use of tyrosine kinase inhibitors for treating bone loss | |
IL143594A0 (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases | |
HK1080733A1 (en) | Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol | |
WO2001081316A3 (en) | Substituted phenyl farnesyltransferase inhibitors | |
HUT74948A (en) | Use of p antagonist for producing pharmaceutical compositions for treating acne, rosacea and/or pubic arythema | |
MY126117A (en) | Pharmaceutical compositions | |
WO2001030331A3 (en) | Therapeutic compositions including protein kinase c inhibitors | |
WO2002015894A3 (en) | Use of vitamin d derivatives as bone resorption inhibitors | |
EP0870502A3 (en) | Use of adenosine uptake inhibitors for the manufacture of a medicament for the treatment of pancreatitis | |
WO2001070233A3 (en) | Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof | |
WO2001060343A3 (en) | Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers | |
WO2002076400A3 (en) | Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease | |
AU2900100A (en) | Methods for inhibiting cathepsin k activity for the treatment of diseases related to bone loss | |
PT1276722E (en) | NAFTAMIDINE-UROQUINASE INHIBITORS | |
HK1080768A1 (en) | Use of epothilone derivatives for the treatment ofhyperparathyroidism | |
WO2003057154A3 (en) | Naaladase inhibitors for treating huntington's disease | |
AU2002211217A1 (en) | Method of treating stroke |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001284657 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2420274 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002520815 Country of ref document: JP Ref document number: 524305 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001963731 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001963731 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10362565 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 524305 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 524305 Country of ref document: NZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001963731 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001284657 Country of ref document: AU |